84 results
Page 4 of 5
424B5
rvrz0dus01by
6 Feb 15
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
mz2 qyt27ku5bpfuhhh
6 Feb 15
Ohr Pharmaceutical Prices $25,000,000 Public Offering of Common Stock
12:00am
8-K
EX-5.1
coiqhg0
6 Feb 15
Ohr Pharmaceutical Prices $25,000,000 Public Offering of Common Stock
12:00am
424B5
ds8tlo4x3 vs7m
5 Feb 15
Prospectus supplement for primary offering
12:00am
8-K
EX-2.1
nucc7
16 May 14
Ohr Pharmaceutical Announces Agreement to Acquire Technology Assets of SKS Ocular
12:00am
8-K
EX-10.41
cfx7o36h ryk01tt
8 Apr 14
Ohr Pharmaceutical Announces $18 Million Registered Direct Offering of Common Stock
12:00am
8-K
EX-10.40
15kl8svr1jmpqnn4xqk
8 Apr 14
Ohr Pharmaceutical Announces $18 Million Registered Direct Offering of Common Stock
12:00am
8-K
EX-10.33
gtz0ghud81un1wb6x
24 May 13
Material Modifications to Rights of Security Holders
12:00am
8-K/A
8fa2x9gd32d88 em3k
21 Jan 11
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
pysa2wfq
13 Jan 11
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
EX-10.1
p6gmxgr im
26 Aug 09
Entry into a Material Definitive Agreement
12:00am
10-K/A
EX-10.6
or9zo5gocn6sk7qcswo
2 Apr 09
Annual report (amended)
12:00am
8-K
EX-10.2
s6thwdr
12 Nov 08
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.4
50ngf2s lzc6d0h
12 Nov 08
Entry into a Material Definitive Agreement
12:00am